The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Perphenazine Market Research Report 2024
Synopsis
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global Perphenazine market was valued at US$ 97.8 million in 2023 and is anticipated to reach US$ 123.2 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
This report aims to provide a comprehensive presentation of the global market for Perphenazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perphenazine.
Report Scope
The Perphenazine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Perphenazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Perphenazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Segment by Type
Oral Forms
Injectable Solution
Segment by Application
Psychosis
Antiemetic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Perphenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Perphenazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global Perphenazine market was valued at US$ 97.8 million in 2023 and is anticipated to reach US$ 123.2 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
This report aims to provide a comprehensive presentation of the global market for Perphenazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perphenazine.
Report Scope
The Perphenazine market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Perphenazine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Perphenazine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
Segment by Type
Oral Forms
Injectable Solution
Segment by Application
Psychosis
Antiemetic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Perphenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Perphenazine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Perphenazine Market Overview
1.1 Product Overview and Scope of Perphenazine
1.2 Perphenazine Segment by Type
1.2.1 Global Perphenazine Market Value Comparison by Type (2024-2030)
1.2.2 Oral Forms
1.2.3 Injectable Solution
1.3 Perphenazine Segment by Application
1.3.1 Global Perphenazine Market Value by Application: (2024-2030)
1.3.2 Psychosis
1.3.3 Antiemetic
1.4 Global Perphenazine Market Size Estimates and Forecasts
1.4.1 Global Perphenazine Revenue 2019-2030
1.4.2 Global Perphenazine Sales 2019-2030
1.4.3 Global Perphenazine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Perphenazine Market Competition by Manufacturers
2.1 Global Perphenazine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Perphenazine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Perphenazine Average Price by Manufacturers (2019-2024)
2.4 Global Perphenazine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Perphenazine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Perphenazine, Product Type & Application
2.7 Perphenazine Market Competitive Situation and Trends
2.7.1 Perphenazine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Perphenazine Players Market Share by Revenue
2.7.3 Global Perphenazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Perphenazine Retrospective Market Scenario by Region
3.1 Global Perphenazine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Perphenazine Global Perphenazine Sales by Region: 2019-2030
3.2.1 Global Perphenazine Sales by Region: 2019-2024
3.2.2 Global Perphenazine Sales by Region: 2025-2030
3.3 Global Perphenazine Global Perphenazine Revenue by Region: 2019-2030
3.3.1 Global Perphenazine Revenue by Region: 2019-2024
3.3.2 Global Perphenazine Revenue by Region: 2025-2030
3.4 North America Perphenazine Market Facts & Figures by Country
3.4.1 North America Perphenazine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Perphenazine Sales by Country (2019-2030)
3.4.3 North America Perphenazine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Perphenazine Market Facts & Figures by Country
3.5.1 Europe Perphenazine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Perphenazine Sales by Country (2019-2030)
3.5.3 Europe Perphenazine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Perphenazine Market Facts & Figures by Country
3.6.1 Asia Pacific Perphenazine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Perphenazine Sales by Country (2019-2030)
3.6.3 Asia Pacific Perphenazine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Perphenazine Market Facts & Figures by Country
3.7.1 Latin America Perphenazine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Perphenazine Sales by Country (2019-2030)
3.7.3 Latin America Perphenazine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Perphenazine Market Facts & Figures by Country
3.8.1 Middle East and Africa Perphenazine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Perphenazine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Perphenazine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Perphenazine Sales by Type (2019-2030)
4.1.1 Global Perphenazine Sales by Type (2019-2024)
4.1.2 Global Perphenazine Sales by Type (2025-2030)
4.1.3 Global Perphenazine Sales Market Share by Type (2019-2030)
4.2 Global Perphenazine Revenue by Type (2019-2030)
4.2.1 Global Perphenazine Revenue by Type (2019-2024)
4.2.2 Global Perphenazine Revenue by Type (2025-2030)
4.2.3 Global Perphenazine Revenue Market Share by Type (2019-2030)
4.3 Global Perphenazine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Perphenazine Sales by Application (2019-2030)
5.1.1 Global Perphenazine Sales by Application (2019-2024)
5.1.2 Global Perphenazine Sales by Application (2025-2030)
5.1.3 Global Perphenazine Sales Market Share by Application (2019-2030)
5.2 Global Perphenazine Revenue by Application (2019-2030)
5.2.1 Global Perphenazine Revenue by Application (2019-2024)
5.2.2 Global Perphenazine Revenue by Application (2025-2030)
5.2.3 Global Perphenazine Revenue Market Share by Application (2019-2030)
5.3 Global Perphenazine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Perphenazine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Perphenazine Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Perphenazine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Perphenazine Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Endo
6.3.1 Endo Corporation Information
6.3.2 Endo Description and Business Overview
6.3.3 Endo Perphenazine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo Perphenazine Product Portfolio
6.3.5 Endo Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Perphenazine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Perphenazine Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 ZHPHARMA
6.5.1 ZHPHARMA Corporation Information
6.5.2 ZHPHARMA Description and Business Overview
6.5.3 ZHPHARMA Perphenazine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ZHPHARMA Perphenazine Product Portfolio
6.5.5 ZHPHARMA Recent Developments/Updates
6.6 Shandong Boshan Pharma
6.6.1 Shandong Boshan Pharma Corporation Information
6.6.2 Shandong Boshan Pharma Description and Business Overview
6.6.3 Shandong Boshan Pharma Perphenazine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Shandong Boshan Pharma Perphenazine Product Portfolio
6.6.5 Shandong Boshan Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Perphenazine Industry Chain Analysis
7.2 Perphenazine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Perphenazine Production Mode & Process
7.4 Perphenazine Sales and Marketing
7.4.1 Perphenazine Sales Channels
7.4.2 Perphenazine Distributors
7.5 Perphenazine Customers
8 Perphenazine Market Dynamics
8.1 Perphenazine Industry Trends
8.2 Perphenazine Market Drivers
8.3 Perphenazine Market Challenges
8.4 Perphenazine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
